Abbott Laboratories – CRI Report

Global TMJ Disorders Market Research Report—Forecast till 2027

admin — Wed, 21 Apr 2021 02:47:09 +0000

Global TMJ Disorders Market Research Report—Forecast till 2027
Market Overview
Global TMJ Disorders Market was valued at USD 650.07 Million in 2019 and is expected to register a CAGR of 4.18 % during the forecast period of 2020 to 2027. Temporomandibular joint and muscle disorders are referred to as TMJ disorder that causes pain in the muscles and joints jaw. The increasing introduction and rapid adoption of advanced treatments and easy availability of medicines, rising prevalence of TMJ disorders, and increase in healthcare expenditure are expected to propel the market growth during the review period.

The global TMJ Disorder Market is expected to register a healthy market growth owing to the increase in technological advancement and increasing prevalence of these disorders. The emergence of non-surgical and surgical treatment methods for TMJ disorders is expected to drive market growth during the review period. TMJ disorders are the second-most commonly occurring musculoskeletal conditions resulting in pain and disability. The occurrences of TMD peaks from the age of 20-40 years, and it is found to be more prevalent in women than men. Additionally, women who use supplemental estrogenic or oral contraceptives are more expected to seek treatment for these conditions. Therefore, the increasing prevalence of these disorders in these populations is further fuelling the market growth during the review period.
Market Segmentation
The Global TMJ Disorders Market has been classified into Type, treatment, and end-user.
Based on type segment, the Global TMJ Disorders Market, based on Type classified into myofascial Pain, Internal Derangement (ID), and Osteoarthritis.
In terms of treatment, the market has been divided into medication, therapies, surgical, and others. The medication segment is further sub-divided into pain relievers, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others.
Based on end-user, the global TMJ disorders market is segmented into hospitals and clinics, ambulatory surgery centers, academic institutes, and others.
Regional Analysis
Geographically, the Global TMJ Disorder Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas market has been divided into North America and Latin America, with the North America market further segmented into the US and Canada. The Americas is expected to dominate the global market owing to the largest share of 49.20% of the TMJ disorder market in 2019. This largest share is driven by the introduction and rapid adoption of advanced treatments in the region.
The European TMJ disorder market has been bifurcated into Western Europe and Eastern Europe. The Western Europe TMJ disorder market has further been divided into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The TMJ disorder market in Asia-Pacific has been classified into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The Middle East & Africa TMJ disorder market has been segmented into the Middle East and Africa.
Major Players
The key players in the global TMJ Disorders market are Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

The post Global TMJ Disorders Market Research Report—Forecast till 2027 first appeared on CRI Report.

Dietary Supplements in the Age of Personalized Nutrition Market Research Report – Global Forecast Till 2023

admin — Fri, 04 Jan 2019 05:53:05 +0000

Market Analysis
With the increasing problems of malnutrition and poor health, it has become very much important for people to get hold of the best dietary supplements. These supplements are consumed to increase the level of consumption. These supplements have biological benefits if consumed regularly. The supplements generally include those substances that are beneficial to health, like fiber, amino acids, minerals, vitamins, fatty acids, and other substances. The global dietary supplements in the age of personalized nutrition market are expected to grow at a CAGR of 6.90% during the forecast period 2017-2023.
One of the main driving forces that are affecting the growth of this market is an individual lifestyle and changing food habits of the people. Fluctuation in the nutrition content of the food is also another factor that is affecting the market. In the age of personalized nutrition, the dietary supplements are considered to be the major reasons for drastic changes in the healthcare sector due to its ability to offer one with improvised drug delivery system along with better patient care or individual treatment process. Advancements made in the preparation of the dietary supplements along with the superior drug formulation processes is expected to uplift the global dietary supplements in the age of personalized nutrition market.
Market Segmentation
The global dietary supplements in the age of personalized nutrition market are categorized on the basis of its product category, gender, application, end user, dosage form and regional demand. Based on its product category, the market is segmented into herbs & botanicals, vitamins, sports supplements, minerals, meal supplements, and others. Based on its gender, the global dietary supplements in the age of personalized nutrition market is segmented into male and female. On the basis of its application, the global market is classified into lifestyle diseases, genetic predispositions, inherited diseases, and others. On the basis of its dosage form, the market is sectioned into tablets, powder, soft gels, capsules, liquids, and others. Based on its end users, the market is divided into home care, hospitals & clinics, and others.
Regional Analysis
Geographically, the global dietary supplements in the age of personalized nutrition market are divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major Players
Some of the major players in the global dietary supplements in the age of personalized nutrition market include companies like Nestlé Health Science, Carlyle Group, Danone Nutricia, Amway (Nutrilite), Abbott Laboratories, Archer Daniels Midland, Herbalife International, Danisco, Amway, Glanbia, GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Balchem Corporation, Bactolac Pharmaceutical Inc., Natures Product Inc., among others.

The post Dietary Supplements in the Age of Personalized Nutrition Market Research Report – Global Forecast Till 2023 first appeared on CRI Report.

Global Capillary Blood Collection Devices Market Research Report – Forecast Till 2023

admin — Fri, 28 Dec 2018 02:47:33 +0000

Market Analysis
Blood Collection for testing assumes a fundamental role in an effective medical treatment at the hospitals, healthcare and diagnostic centers all over the world. Blood test accumulation method incorporates a chain of sequence, and each sequence of this grouping is very imperative to keep up high-quality clinical outcomes. Global capillary blood collection devices market is anticipated to grow at a CAGR of 10.0% during the forecast period 2017–2023.
It has been noticed that the medical device regulation is the key factor driving the growth of the capillary blood collection devices market. Control of the usage of a medical device must be upgraded and improvised to protect the well-being of the patient. It must be ensured that high-quality products and effective technologies reach the patients. Developing interest for analysis of chronic diseases, the rising prevalence of diabetes, and expanding geriatric populace are additionally energizing the market development. However, the higher risk related to the capillary blood assortment technologies leading to blood contaminations may restrict the growth of the capillary blood collection devices market.
Market Segmentation
The global capillary blood collection devices market is divided on the basis of its type of devices, material, and end-user industry. On the basis of its type of devices, the global capillary blood collection devices market is bifurcated into lancets, blood collecting tubes and collector, and warming devices. Based on its material, the global market is classified into glass, plastic, stainless steel, and others. Based on its end -user, the market is sectioned into clinics, hospitals, home diagnostics, diagnostic centers and pathology laboratories, and others.
Regional Analysis
Geographically, the global capillary blood collection devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major Players
Some of major players in the capillary blood collection devices market include companies like F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Novo Nordisk A S, Medtronic PLC, B. Braun Melsungen AG, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Ypsomed Holding AG, Terumo Corporation, HTL-STREFA S.A., Sarstedt AG & Co, Greiner Bio-One, Owen Mumford Ltd., Improve Medical, Weigao Group, Chengdu Rich Science Industry Co., Ltd., Nipro, Weihai Hongyu Medical Devices, Medigard, and others.

The post Global Capillary Blood Collection Devices Market Research Report – Forecast Till 2023 first appeared on CRI Report.

Global Active Pharmaceutical Ingredients Market Research Report – Forecast to 2023

admin — Fri, 07 Dec 2018 02:40:51 +0000

Introduction
Active pharmaceutical ingredient (API) is a biologically active pharmaceutical drug. API can be obtained by a synthetic process or from natural sources. The increasing occurrence of chronic diseases, rising acceptance, and uptake of pharmaceuticals, growth in abbreviated new drug applications (ANDA), and the growing importance of generics are expected to drive market growth. For instance, according to the report published by the Centers for Disease Control and Prevention (CDC), nearly 92.1 million adults in the US dealt with at least one type of cardiovascular diseases in 2017. However, stringent regulatory policies and adverse drug price control policies across numerous countries may hamper the growth of the market.
The global active pharmaceutical ingredient market is expected to reach to a market value of USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023. In 2016, the market was led by the Americas with a 40.7% share, followed by Europe and Asia-Pacific with shares of 27.0% and 24.8%, respectively. The increasing burden of chronic diseases has been observed in different parts of the world which has upsurge the growth of the market.
The global active pharmaceutical ingredients market is segmented by manufacturing process, by type of synthesis, by API formulation, by application, by molecule, and by region.
The global active pharmaceutical ingredients market, by manufacturing process, is segmented into captive manufacturing and contract manufacturing.
The global active pharmaceutical ingredients market, by type of synthesis, is segmented into synthetic and biotech.
The global active pharmaceutical ingredients market, by API formulation, is segmented into generic API and innovative API.
By application, the global active pharmaceutical ingredients market is segmented into cardiovascular disease, oncology, neurological disorders, orthopedic disorders, respiratory, gastrointestinal disorders, urology, and others.
By molecule, the global active pharmaceutical ingredients market is segmented into small molecule and large molecule.
The global active pharmaceutical ingredient market is expected to reach to a market value of USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023.
Key Players
Sanofi, Bayer AG, Pfizer Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Merck & Co., Inc, Boehringer Ingelheim GmbH, GlaxoSmithKline Plc (GSK), Novartis AG, Eli Lilly and Company, and Teva Pharmaceutical Industries Ltd, and others.
Study objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the active pharmaceutical ingredients market
• To provide insights into factors affecting the market growth
• To analyze the global active pharmaceutical ingredients market based on various tools such as supply chain analysis and Porter’s five force analysis
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
• To provide country-level analysis of the market with respect to current market size and future perspective
• To provide country-level analysis of the market for segments by manufacturing process, by type of synthesis, by API formulation, by application, by molecule, and by region
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the active pharmaceutical ingredients market
Target Audience
• Pharmaceutical and Biotechnology Companies
• Research and Development (R&D) Companies
• Government Research Institutes
• Academic Institutes and Universities
Key Findings
• The global active pharmaceutical ingredients market is expected to reach USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023.
• On the basis of manufacturing process, the captive manufacturing segment is expected to account for the largest market share at a CAGR of 4.78% by 2023
• Based on type of synthesis, the synthetic segment is expected to account for the largest market share at a CAGR of 4.89% by 2023
• Based on API formulation, the generic API segment is expected to account for the largest market share at a CAGR of 4.62% by 2023
• Based on application, the cardiovascular disease segment is expected to account for the largest market share at a CAGR of 3.74% by 2023
• Based on molecule, the small molecule segment is expected to account for the largest market share at a CAGR of 4.89% by 2023
• The Americas is expected to hold the largest share of the global active pharmaceutical ingredients market at a CAGR of 4.74% by 2023
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 5.27% by 2023
Regional Analysis
• Americas
o North America
 US
 Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

The post Global Active Pharmaceutical Ingredients Market Research Report – Forecast to 2023 first appeared on CRI Report.

America Pouchitis Treatment Market Research Report to 2023

admin — Fri, 17 Aug 2018 08:31:04 +0000

America Pouchitis Treatment Market

Pouchitis is a nonspecific inflammatory condition in the ileal pouch reservoir. It is a common complication following proctocolectomy and ileal pouch-anal anastomosis.

The condition exclusively occurs in patients with underlying Ulcerative Colitis (UC) and is rarely seen in patients with Familial Adenomatous Polyposis (FAP). Patients with UC or FAP opt for the Ileal Pouch-Anal Anastomosis (IPAA) surgery as a treatment and pouchitis appear as an outcome of this surgery in some cases.

On the basis of treatment, the Americas pouchitis treatment market is classified into antibiotics, probiotics, and others. The antibiotics segment held the largest market share in 2016.

On the basis of end-user, the Americas pouchitis treatment market is segmented into hospitals and clinics, research institutes, and others. In 2016, hospitals and clinics accounted for the largest share in the Americas pouchitis treatment market.

Regionally, the market is segmented into North America and South America. North America held the largest market share in 2016 and is estimated to reach USD 15.06 million by 2023.

Key Players

The key players in the Americas IBS treatment market are Allergan Plc, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Valeant Pharmaceuticals, Abbott Laboratories, Synergy Pharmaceuticals, Inc., Ardelyx, Inc., Nestle, Sebela Pharmaceuticals, Probi, Alfasigma USA, Inc., and others.

Study objectives

• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide historical and forecast revenue of market segments based on treatment, end-user, and region.
• To provide strategic profiling of key players in the market and comprehensively analyze their market share, core competencies, and draw a competitive landscape for the market
• To provide economic factors that influence the Americas pouchitis treatment market
• To provide a detailed analysis of the value chain and supply chain of the Americas pouchitis treatment market
Target Audience
• Pharmaceutical and Biotech Industries
• Potential Investors
• Medical Research Institutes
• Key Executive (CEO and COO) and Strategy Growth Managers
• Research Companies

Key Findings

• The major companies operating in the market are, Allergan Plc, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Valeant Pharmaceuticals, and Abbott Laboratories, among others

• Antibiotics segment registered USD 8.94 million market revenue in the year 2016 and is expected to grow during the forecast period
• Hospitals and clinics are the fastest-growing segment, by end-user

Regional Analysis
Americas
• North America
o the U.S.
o Canada
• South America

Global Genomic Cancer Testing Market 2029

Bone And Joint Health Ingredient

The post America Pouchitis Treatment Market Research Report to 2023 first appeared on CRI Report.